Insulet will have more cushion than investors anticipated before competition converges on its Omnipod 5 Automated Insulin Delivery (AID) System, cleared by the US Food and Drug Administration on 26 August for use in adults with type 2 diabetes.
The expanded indication marks Omnipod 5 as the first and only AID system cleared for both type 1 and type...